Pharmaceutical Market Europe • October 2022 • 5
CONTENTS
October 2022
NEWS & COLUMNS
6-7 NEWS
MIT develop AI to detect Parkinson's; Amgen announces Lumakras results
8-9 NEWS
AstraZeneca announces Farxiga data; AbbVie's Imbruvica gets FDA approval
10-11 CORONAVIRUS NEWS
WHO announces new global fund; Moderna's bivalent booster recommended
12 DARWIN'S MEDICINE
COVID-19's consequences
13 PUBLIC HEALTH AND POLICY
A day late and a dollar short
14 TALKING ABOUT WELL-BEING
Five key areas to support workplace well-being
15 PHARMA STRATEGIST’S BLOG
The societal health paradigm shift
FEATURES
16-17 ESMO 2022 CONGRESS
ESMO 2002 in Paris showcased the many exciting breakthroughs that are changing the future of oncology
18-19 CAR-T CELL THERAPY IN ONCOLOGY
The future of cancer treatments is here with cell and gene therapies bringing new options to patients
20-21 CLINICAL TRIAL ENGAGEMENT
In-person community engagement remains key to dismantling decades-old barriers
24-25 VALUE-BASED HEALTHCARE Value-based approaches to spending has the potential to unlock long-term success for patients
26-27 RARE DISEASES
Using real-world evidence from rare diseases is crucial to accelerat product approval and development
COMMUNIQUE
MARKETING & COMMS
30-31 ANTIMICROBIAL RESISTANCE
The pandemic moved social media’s focus to COVID-19 but, almost three years on, the interest in AMR remains low
34-35 UK MARKET ACCESS
Optimising market access for innovative medicines in the current UK environment
36-37 CROSS-FUNCTIONAL ALIGNMENT
How important is cross-functional training and alignment for strategy execution?
41 HEALTHCARE COMMS
WE Communications acquires Hopscotch Consulting; Fishawack Health acquires US healthcare consultancy firm Avalere
42 Q&A
An interview with Janet Hemingway CBA, founding director of iiCon Consortium
CAREERS & RECRUITMENT
38-40 APPOINTMENTS
Changes at Novartis, Merck and OPEN Health
43 PHARMA MARKETING JOBS
Jobs in pharma marketing, sales and communications